FDA Medical devices recall ·
Apo B Reagent recall
- Recall number
- Z-1815-2025
- Date
- (initiated April 23, 2025)
- Company / brand
- Beckman Coulter Ireland, Inc.
Lismeehan, O'Callaghan'S Mills, N/A, Ireland - Category
- Medical devices › Class III
- Classification
- Class III
- Status
- Ongoing
- Units affected
- 2747 units
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
Apo B Reagent, REF: OSR6143
Why was it recalled?
The product Value Assignment Sheet (VAS) is used in calibration of the device. An erroneous value was included in the VAS which has the potential to generate an incorrect APO B patient result which could exceed the total allowable error for the APO B assay (11.6%). The error results in results with a positive bias up to 42%. However, based on the mitigating factors the risk to health is considered to be negligible or limited.
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot # 2631/UDI: 15099590010409
Distribution
Worldwide - US Nationwide distribution in the states of AZ, CA, CO, FL, GA, IL, IN, MD, MI, NJ, NY, OH, OK, OR, PA, TX, VA, WA, WV and the countries of Argentina, Australia, Belarus, Belgium, Bulgaria, Canada, China, Czechia, Egypt, Estonia, France, Germany, Ghana, Greece, Hong Kong, India, Ireland, Israel, Italy, Korea, Republic of, Malaysia, Netherlands, New Zealand, Russian Federation, Saudi Arabia, Slovakia, Spain, Switzerland, Taiwan, Province of China, United Kingdom of Great Britain and Northern Ireland, United States of America, Viet Nam.
States: Arizona California Colorado Florida Georgia Illinois Indiana Maryland Michigan New Jersey New York Ohio Oklahoma Oregon Pennsylvania Texas Virginia Washington West Virginia
What does Class III mean?
Class III means use of or exposure to the product is not likely to cause adverse health consequences (for example, a labeling violation).
Source: FDA (medical devices), recall Z-1815-2025. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.